HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Links / Leveraging Simulation to Patch a Clinical Trial Broken by COVID-19

Leveraging Simulation to Patch a Clinical Trial Broken by COVID-19

The basic structure of a randomized comparative clinical trial is quite simple. A candidate population that meets the admissibility criteria is recruited. Each candidate who consents to participate is randomly allocated to an experimental treatment or to one or more “controls.” The participants are followed and data are collected until a pre-specified ending criterion is met. To ensure the integrity and usefulness of the trial, it is important that there be sufficient numbers of participants, they be followed as specified without losses, and all desired data be collected. Failure to do so increasingly threatens the informativeness of the trial, and if the losses are biased in some way, the validity of the trial can also be jeopardized. Medical research has become quite adept at meeting the design and operational challenges posed, but the COVID-19 pandemic has inflicted unexpected damages to ongoing trials.

The enormous investments involved and the substantial adverse consequences of failing to gain the desired information from these trials put enormous pressure on our field to find ways of patching the broken trials. In this brief paper, we provide one novel solution to these problems: using simulation to attempt to rescue these studies and make up for the lost data.

Click here for more information about this report.



You might also be interested in:

  • Syapse and FDA Leverage Real-World Data to Study Impact of… 10/05/2020
  • Jeff Anderson Joins OPEN Health as European Lead for OPEN VIE… 06/16/2020
  • How HEOR Professionals Can Be Force Multipliers in the Fight… 10/06/2020
  • [Book Release] Value-Based Drug Pricing Guide on Flawed $500… 03/10/2021
  • Trump's "Buy American" Executive Order Could Raise Drug Prices 08/06/2020
  • What Does $11M in Donations to Congress Buy Pharma? 08/12/2020
  • Using AI, NLP and Data Visualization with RWE to Generate… 06/10/2020

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters

Syndicated Reports

Artificial Intelligence in Healthcare Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Component, Application, End User, and Geography

Healthcare Trends & Forecasts in 2021: Performance Expectations for the Healthcare Industry

Medical Affairs Outsourcing Market 2021 Overview, Trends, Size, Growth and 2028 Future Insights

Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

White Papers

Beyond The Field: Evolving Field Medical Engagement And Talent For The Future

Innovating the Delivery of Patient Support: Branded Patient Support programs for Today’s Health Consumer

Healthcare Cost Containment: Best Practices & Recommendations

How Payers Can Outpace Market Competition

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute